Related Experiment Video
Updated: Jul 15, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Syk from M1 macrophage exosomes drives vascular injury in kidney transplant rejection
Jinxu Miao1, Yuxi Chen1, Zhou Hang1
1Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
Abstract:
Antibody-mediated rejection (ABMR) remains a leading cause of renal allograft failure, characterized by peritubular capillaritis and endothelial inflammation. M1-polarized macrophages are abundantly recruited to allograft tissues during ABMR. However, the role of their secreted exosomes in vascular injury remains insufficiently defined. Here, we demonstrate that exosomes derived from M1 macrophages (M1-Exos) potently induce endothelial activation and inflammatory injury. Through transcriptomic and exosomal proteomic analyses, spleen tyrosine kinase (Syk) was identified as a protein significantly enriched in M1-Exos. Functional assays showed that M1-Exos promote the upregulation of ICAM-1, VCAM-1, and inflammatory cytokines in endothelial cells, while genetic knockdown of Syk in M1 macrophage reduced these effects. Mechanistically, exosomal Syk is transferred to endothelial cells and associates with NLRP3, driving inflammasome activation and caspase-1 cleavage. In a murine model of renal transplant, Syk-enriched exosomes aggravated endothelial injury. Meanwhile, Syk-deficient exosomes attenuated endothelial inflammation signs of ABMR in grafts. These findings identify exosomal Syk as a novel mediator of endothelial inflammation and provide insights into macrophage-endothelium communication in the setting of allograft rejection.
Insights
M1 macrophage exosomes, enriched with spleen tyrosine kinase (Syk), drive kidney transplant rejection by activating endothelial cells. Inhibiting Syk in these exosomes reduces vascular injury and rejection signs.
Area of Science:
- Immunology
- Transplantation Biology
- Cell Biology
Background:
- Antibody-mediated rejection (ABMR) is a major cause of kidney transplant failure, involving inflammation and damage to blood vessels.
- M1-polarized macrophages accumulate in rejected allografts, but their exosomes' role in vascular injury is unclear.
Purpose of the Study:
- To investigate the role of exosomes secreted by M1 macrophages (M1-Exos) in endothelial injury during ABMR.
- To identify specific molecules within M1-Exos mediating this vascular damage.
Main Methods:
- Transcriptomic and proteomic analysis of M1-Exos to identify key proteins.
- In vitro functional assays using endothelial cells to assess M1-Exo effects.
- Inhibition and genetic deletion of identified proteins (Syk) to determine their role.
- Murine model of renal transplantation to evaluate M1-Exo effects in vivo.
Main Results:
- M1-Exos significantly induce endothelial activation, upregulating ICAM-1 and VCAM-1.
- Spleen tyrosine kinase (Syk) was identified as highly enriched in M1-Exos.
- Exosomal Syk transfer to endothelial cells activates the NLRP3 inflammasome and caspase-1.
- Inhibition or absence of Syk in M1-Exos reduced endothelial inflammation and ABMR severity in a murine model.
Conclusions:
- Exosomes derived from M1 macrophages mediate endothelial inflammation and vascular injury in ABMR.
- Exosomal Syk is a key mediator, transferred from M1 macrophages to endothelial cells, driving inflammasome activation.
- Targeting exosomal Syk presents a potential therapeutic strategy for mitigating ABMR and improving transplant outcomes.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Kidney Transplant I: Introduction
Cytotoxic Edema: Pathophysiology
Cell-mediated Immune Responses
Kidney Transplant II: Surgical Procedure